A comprehensive proteomic analysis of Mycobacterium bovis bacillus Calmette-Guérin using high resolution Fourier transform mass spectrometry

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 357-371

  Zheng, Jianhua ^a   Liu, Liguo ^a   Wei, Candong ^a   Leng, Wenchuan ^a   Yang, Jian ^a   Li, Weijun ^a   Wang, Jin ^a   Jin, Qi ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

Comprehensive proteomic analysis; LTQ Orbitrap Velos mass spectrometer; Mycobacterium bovis bacillus Calmette Gu rin; Pseudogene; RT PCR

Indexed keywords

ANTIGEN; BCG VACCINE; CARRIER PROTEIN; HEAT SHOCK PROTEIN; LIPOPROTEIN; MEMBRANE PROTEIN; PEPTIDE; PROLYLGLUTAMINE; PROLYLPROLYLGLUTAMINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FOURIER TRANSFORM MASS SPECTROMETRY; FUNCTIONAL PROTEOMICS; GENETIC TRANSCRIPTION; HUMORAL IMMUNITY; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MOLECULAR WEIGHT; MYCOBACTERIUM BOVIS; NONHUMAN; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSLATION INITIATION;

BACTERIAL PROTEINS; BCG VACCINE; MASS SPECTROMETRY; MYCOBACTERIUM BOVIS; PROTEOME; PROTEOMICS; TUBERCULOSIS; VACCINATION;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

EID: 84870393056     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.09.010     Document Type: Article

References (66)

1. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999, 284:1520-1523.
2. Dye C. Global epidemiology of tuberculosis. Lancet 2006, 367:938-940.
3. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996, 178:1274-1282.
4. Sakula A. BCG: who were Calmette and Guerin?. Thorax 1983, 38:806-812.
5. Brewer T.F. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000, 31(Suppl. 3):S64-S67.
6. Andersen P., Doherty T.M. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005, 3:656-662.
7. Girard M.P., Fruth U., Kieny M.P. A review of vaccine research and development: tuberculosis. Vaccine 2005, 23:5725-5731.
8. Rodriguez-Alvarez M., Mendoza-Hernandez G., Encarnacion S., Calva J.J., Lopez-Vidal Y. Phenotypic differences between BCG vaccines at the proteome level. Tuberculosis (Edinb) 2009, 89:126-135.
9. Rabilloud T., Chevallet M., Luche S., Lelong C. Two-dimensional gel electrophoresis in proteomics: past, present and future. J Proteomics 2010, 73:2064-2077.
10. Jungblut P.R., Schaible U.E., Mollenkopf H.J., Zimny-Arndt U., Raupach B., Mattow J., et al. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999, 33:1103-1117.
11. Rabilloud T., Vaezzadeh A.R., Potier N., Lelong C., Leize-Wagner E., Chevallet M. Power and limitations of electrophoretic separations in proteomics strategies. Mass Spectrom Rev 2009, 28:816-843.
12. Gu S., Chen J., Dobos K.M., Bradbury E.M., Belisle J.T., Chen X. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol Cell Proteomics 2003, 2:1284-1296.
13. Xiong Y., Chalmers M.J., Gao F.P., Cross T.A., Marshall A.G. Identification of Mycobacterium tuberculosis H37Rv integral membrane proteins by one-dimensional gel electrophoresis and liquid chromatography electrospray ionization tandem mass spectrometry. J Proteome Res 2005, 4:855-861.
14. Zheng J., Wei C., Leng W., Dong J., Li R., Li W., et al. Membrane subproteomic analysis of Mycobacterium bovis bacillus Calmette-Guerin. Proteomics 2007, 7:3919-3931.
15. Mattow J., Siejak F., Hagens K., Schmidt F., Koehler C., Treumann A., et al. An improved strategy for selective and efficient enrichment of integral plasma membrane proteins of mycobacteria. Proteomics 2007, 7:1687-1701.
16. Malen H., Berven F.S., Softeland T., Arntzen M.O., D'Santos C.S., De Souza G.A., et al. Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics 2008, 8:1859-1870.
17. Berredo-Pinho M., Kalume D.E., Correa P.R., Gomes L.H., Pereira M.P., da Silva R.F., et al. Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur. BMC Microbiol 2011, 11:80.
18. Zheng J., Wei C., Zhao L., Liu L., Leng W., Li W., et al. Combining blue native polyacrylamide gel electrophoresis with liquid chromatography tandem mass spectrometry as an effective strategy for analyzing potential membrane protein complexes of Mycobacterium bovis bacillus Calmette-Guerin. BMC Genomics 2011, 12:40.
19. Rison S.C., Mattow J., Jungblut P.R., Stoker N.G. Experimental determination of translational starts using peptide mass mapping and tandem mass spectrometry within the proteome of Mycobacterium tuberculosis. Microbiology 2007, 153:521-528.
20. Wu C.C., MacCoss M.J., Howell K.E., Yates J.R. A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol 2003, 21:532-538.
21. Bell C., Smith G.T., Sweredoski M.J., Hess S. Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research. J Proteome Res 2012, 11:119-130.
22. Florio W., Freer G., Daila Casa B., Batoni G., Maisetta G., Senesi S., et al. Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis bacillus Calmette-Guerin. Can J Microbiol 1997, 43:744-750.
23. Florio W., Batoni G., Esin S., Bottai D., Maisetta G., Pardini M., et al. Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guerin in the isoelectric point range 6-11. Proteomics 2003, 3:798-802.
24. Mollenkopf H.J., Grode L., Mattow J., Stein M., Mann P., Knapp B., et al. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis. Infect Immun 2004, 72:6471-6479.
25. Orduna P., Cevallos M.A., de Leon S.P., Arvizu A., Hernandez-Gonzalez I.L., Mendoza-Hernandez G., et al. Genomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection. BMC Genomics 2011, 12:493.
26. Lew J.M., Kapopoulou A., Jones L.M., Cole S.T. TubercuList-10 years after. Tuberculosis (Edinb) 2011, 91:1-7.
27. Lerat E., Ochman H. Psi-Phi: exploring the outer limits of bacterial pseudogenes. Genome Res 2004, 14:2273-2278.
28. Lerat E., Ochman H. Recognizing the pseudogenes in bacterial genomes. Nucleic Acids Res 2005, 33:3125-3132.
29. Brosch R., Gordon S.V., Garnier T., Eiglmeier K., Frigui W., Valenti P., et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A 2007, 104:5596-5601.
30. Zhu H.Q., Hu G.Q., Ouyang Z.Q., Wang J., She Z.S. Accuracy improvement for identifying translation initiation sites in microbial genomes. Bioinformatics 2004, 20:3308-3317.
31. Nielsen P., Krogh A. Large-scale prokaryotic gene prediction and comparison to genome annotation. Bioinformatics 2005, 21:4322-4329.
32. de Souza G.A., Malen H., Softeland T., Saelensminde G., Prasad S., Jonassen I., et al. High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics 2008, 9:316.
33. Link A.J., Robison K., Church G.M. Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis 1997, 18:1259-1313.
34. Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K., et al. Proteogenomic analysis of Mycobacterium tuberculosis by high resolution mass spectrometry. Mol Cell Proteomics 2011, 10(M111):011627.
35. Zhou L., Ying W., Han Y., Chen M., Yan Y., Li L., et al. A proteome reference map and virulence factors analysis of Yersinia pestis 91001. J Proteomics 2012, 75:894-907.
36. He Z., De Buck J. Cell wall proteome analysis of Mycobacterium smegmatis strain MC2 155. BMC Microbiol 2010, 10:121.
37. Wallin E., von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci 1998, 7:1029-1038.
38. Sutcliffe I.C., Harrington D.J. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. FEMS Microbiol Rev 2004, 28:645-659.
39. Mukhopadhyay S., Balaji K.N. The PE and PPE proteins of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2011, 91:441-447.
40. Abdallah A.M., Verboom T., Weerdenburg E.M., van Pittius NC Gey, Mahasha P.W., Jimenez C., et al. PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol Microbiol 2009, 73:329-340.
41. Voskuil M.I., Schnappinger D., Rutherford R., Liu Y., Schoolnik G.K. Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb) 2004, 84:256-262.
42. Banu S., Honore N., Saint-Joanis B., Philpott D., Prevost M.C., Cole S.T. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?. Mol Microbiol 2002, 44:9-19.
43. Akhter Y., Ehebauer M.T., Mukhopadhyay S., Hasnain S.E. The PE/PPE multigene family codes for virulence factors and is a possible source of mycobacterial antigenic variation: perhaps more?. Biochimie 2012, 94:110-116.
44. Prakash P., Yellaboina S., Ranjan A., Hasnain S.E. Computational prediction and experimental verification of novel IdeR binding sites in the upstream sequences of Mycobacterium tuberculosis open reading frames. Bioinformatics 2005, 21:2161-2166.
45. Baliko Z., Szereday L., Szekeres-Bartho J. Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy. FEMS Immunol Med Microbiol 1998, 22:199-204.
46. Tundup S., Pathak N., Ramanadham M., Mukhopadhyay S., Murthy K.J., Ehtesham N.Z., et al. The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response. PLoS One 2008, 3:e3586.
47. Skeiky Y.A., Ovendale P.J., Jen S., Alderson M.R., Dillon D.C., Smith S., et al. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol 2000, 165:7140-7149.
48. Choudhary R.K., Mukhopadhyay S., Chakhaiyar P., Sharma N., Murthy K.J., Katoch V.M., et al. PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response. Infect Immun 2003, 71:6338-6343.
49. Khan N., Alam K., Nair S., Valluri V.L., Murthy K.J., Mukhopadhyay S. Association of strong immune responses to PPE protein Rv1168c with active tuberculosis. Clin Vaccine Immunol 2008, 15:974-980.
50. Abdallah A.M., Savage N.D., van Zon M., Wilson L., Vandenbroucke-Grauls C.M., van der Wel N.N., et al. The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response. J Immunol 2008, 181:7166-7175.
51. Sander P., Rezwan M., Walker B., Rampini S.K., Kroppenstedt R.M., Ehlers S., et al. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol 2004, 52:1543-1552.
52. Young D.B., Garbe T.R. Lipoprotein antigens of Mycobacterium tuberculosis. Res Microbiol 1991, 142:55-65.
53. Shin D.M., Yuk J.M., Lee H.M., Lee S.H., Son J.W., Harding C.V., et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 2010, 12:1648-1665.
54. Fol M., Chauhan A., Nair N.K., Maloney E., Moomey M., Jagannath C., et al. Modulation of Mycobacterium tuberculosis proliferation by MtrA, an essential two-component response regulator. Mol Microbiol 2006, 60:643-657.
55. Sassetti C.M., Boyd D.H., Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003, 48:77-84.
56. Lefevre P., Braibant M., de Wit L., Kalai M., Roeper D., Grotzinger J., et al. Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J Bacteriol 1997, 179:2900-2906.
57. Qamra R., Mande S.C., Coates A.R., Henderson B. The unusual chaperonins of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2005, 85:385-394.
58. Young D.B., Garbe T.R. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun 1991, 59:3086-3093.
59. Sakoh M., Ito K., Akiyama Y. Proteolytic activity of HtpX, a membrane-bound and stress-controlled protease from Escherichia coli. J Biol Chem 2005, 280:33305-33310.
60. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003, 16:463-496.
61. Banerjee S.K., Misra P., Bhatt K., Mande S.C., Chakraborti P.K. Identification of an ABC transporter gene that exhibits mRNA level overexpression in fluoroquinolone-resistant Mycobacterium smegmatis. FEBS Lett 1998, 425:151-156.
62. Jarlier V., Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 1994, 123:11-18.
63. Schuldiner S. Structural biology: the ins and outs of drug transport. Nature 2006, 443:156-157.
64. Domenech P., Reed M.B., Barry C.E. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun 2005, 73:3492-3501.
65. Axelsen K.B., Palmgren M.G. Evolution of substrate specificities in the P-type ATPase superfamily. J Mol Evol 1998, 46:84-101.
66. Renshaw P.S., Lightbody K.L., Veverka V., Muskett F.W., Kelly G., Frenkiel T.A., et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 2005, 24:2491-2498.